Status:
COMPLETED
FDG Uptake in Vaginal Tampons is Due to Urine
Lead Sponsor:
Irene Burger
Conditions:
Cancer
Eligibility:
FEMALE
20-48 years
Phase:
NA
Brief Summary
The etiology of FDG uptake in vaginal tampons during PET/CT examinations remains unclear and can potentially impair image interpretation. The aim of this study is to determine the etiology of this ar...
Detailed Description
In this prospective, Institutional Review board approved study we included 44 women referred to FDG PET/CT for staging or follow-up in an oncology setting. All women were provided a normal commercial ...
Eligibility Criteria
Inclusion
- Inclusion criteria: premenopausal women with known or suspected malignancies who regularly used vaginal tampons during menstruation and thus were familiar with their use
- Exclusion criteria: No cervical or genital carcinoma. No vaginal infection.
Exclusion
Key Trial Info
Start Date :
February 2 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2010
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT01215318
Start Date
February 2 2010
End Date
September 30 2010
Last Update
August 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich
Zurich, Switzerland, 8091